News

Cardiologists report early favorable outcomes using a leaflet modification device to facilitate valve-in-valve TAVR procedures. The device appears to address challenges associated with coronary obstruction risk during ViV-TAVR interventions.

Digest: Leaflet modification techniques may expand treatment options for patients with failed surgical bioprostheses by reducing coronary obstruction risk, a major limitation of valve-in-valve TAVR.

A high-intensity ultrasound technology designed to treat calcified valve leaflets has launched in Europe. No specific clinical data or device details were provided in the article content.

Digest: Novel leaflet modification technologies could expand treatment options for calcified valves, though clinical validation data are needed to assess utility in structural heart interventions.

Cardiologists performed the first-in-world transcatheter aortic valve replacement using a novel leaflet-splitting technique. No specific procedural outcomes or patient data were provided in the available article content.

Digest: This first-in-human procedural innovation may represent a new approach to address leaflet-related complications during TAVR, though clinical benefits remain to be demonstrated.